Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M701813200 on June 13, 2007

J. Biol. Chem., Vol. 282, Issue 35, 25436-25444, August 31, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/35/25436    most recent
M701813200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freundlich, J. S.
Right arrow Articles by Sacchettini, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freundlich, J. S.
Right arrow Articles by Sacchettini, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

X-ray Structural Analysis of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase as a Pathway toward the Optimization of Triclosan Antimalarial Efficacy*Formula

Joel S. Freundlich{ddagger}1, Feng Wang§, Han-Chun Tsai§, Mack Kuo§, Hong-Ming Shieh{ddagger}, John W. Anderson{ddagger}, Louis J. Nkrumah, Juan-Carlos Valderramos2, Min Yu2, T. R. Santha Kumar, Stephanie G. Valderramos2, William R. Jacobs, Jr||, Guy A. Schiehser{ddagger}, David P. Jacobus{ddagger}, David A. Fidock2, and James C. Sacchettini§3

From the {ddagger}Department of Medicinal Chemistry, Jacobus Pharmaceutical Company, Princeton, New Jersey 08540, the §Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843-2128, the Department of Microbiology and Immunology and the ||Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York 10461

The x-ray crystal structures of five triclosan analogs, in addition to that of the isoniazid-NAD adduct, are described in relation to their integral role in the design of potent inhibitors of the malarial enzyme Plasmodium falciparum enoyl acyl carrier protein reductase (PfENR). Many of the novel 5-substituted analogs exhibit low micromolar potency against in vitro cultures of drug-resistant and drug-sensitive strains of the P. falciparum parasite and inhibit purified PfENR enzyme with IC50 values of <200 nM. This study has significantly expanded the knowledge base with regard to the structure-activity relationship of triclosan while affording gains against cultured parasites and purified PfENR enzyme. In contrast to a recent report in the literature, these results demonstrate the ability to improve the in vitro potency of triclosan significantly by replacing the suboptimal 5-chloro group with larger hydrophobic moieties. The biological and x-ray crystallographic data thus demonstrate the flexibility of the active site and point to future rounds of optimization to improve compound potency against purified enzyme and intracellular Plasmodium parasites.


Received for publication, March 1, 2007 , and in revised form, June 5, 2007.

* This work was supported by funding from the Medicines for Malaria Venture and National Institutes of Health Grants AI060342 and AI43268. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and structure factors (code 2NQ8, 2FOI, 2OOS, 2OL4, 2OP0, and 2OP1) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1 and Figs. S1–S7.

2 Present address: Depts. of Microbiology and of Medicine, Columbia University, New York, NY 10032.

3 Supported by Robert A. Welch Foundation Grant A-0015.

1 To whom correspondence should be addressed: Dept. of Chemistry, Princeton University, Frick Chemical Laboratory, Princeton, NJ 08544. Tel.: 609-258-9804; Fax: 609-258-1980; E-mail: joelf{at}princeton.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement